John Ransom
Stock Analyst at Raymond James
(3.67)
# 761
Out of 5,245 analysts
208
Total ratings
65.43%
Success rate
15.83%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Upgrades: Outperform | $330 | $388.47 | -15.05% | 14 | Apr 1, 2026 | |
| LMRI Lumexa Imaging Holdings | Upgrades: Strong Buy | $23 | $8.00 | +187.50% | 2 | Feb 9, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $23.18 | +29.42% | 10 | Oct 3, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $54.40 | +37.87% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $7.33 | +22.78% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $77.39 | +16.29% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $173.78 | +15.09% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $286.24 | +34.50% | 18 | May 5, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $394.07 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.80 | - | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $10 | $2.64 | +278.79% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $104.96 | -9.49% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $307.95 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $22.64 | -11.66% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $8.92 | +236.32% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $16.35 | -26.61% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $93.26 | -8.86% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $92.65 | +13.33% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $5.33 | +87.62% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.29 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.98 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $23.81 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $198.52 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.37 | - | 2 | Aug 9, 2017 |
UnitedHealth Group
Apr 1, 2026
Upgrades: Outperform
Price Target: $330
Current: $388.47
Upside: -15.05%
Lumexa Imaging Holdings
Feb 9, 2026
Upgrades: Strong Buy
Price Target: $23
Current: $8.00
Upside: +187.50%
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $23.18
Upside: +29.42%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $54.40
Upside: +37.87%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $7.33
Upside: +22.78%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $77.39
Upside: +16.29%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $173.78
Upside: +15.09%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $286.24
Upside: +34.50%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $394.07
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.80
Upside: -
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $2.64
Upside: +278.79%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $104.96
Upside: -9.49%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $307.95
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $22.64
Upside: -11.66%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $8.92
Upside: +236.32%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $16.35
Upside: -26.61%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $93.26
Upside: -8.86%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $92.65
Upside: +13.33%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $5.33
Upside: +87.62%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.29
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $21.98
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $23.81
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $198.52
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $13.37
Upside: -